{"id":"W4386881349","doi":"10.1056/nejmoa2303815","title":"Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations","year":2023,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Brain Tumour Charity; Novartis Pharmaceuticals Corporation","keywords":"Dabrafenib; Trametinib; Glioma; Medicine; Oncology; Internal medicine; Cancer research; Biology; Melanoma; Genetics; MAPK/ERK pathway; Vemurafenib; Kinase; Metastatic melanoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006429176,0.0001817216,0.0005998387,0.0009935668,0.00004130135,0.00001048288,0.00009657618,0.0000631858,0.0001592637],"category_scores_gemma":[0.0003608633,0.0001040631,0.00007736998,0.001518393,0.00006680987,0.00008732696,0.00001272565,0.0003204876,0.00002801811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008428951,"about_ca_system_score_gemma":0.0003486004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001072309,"about_ca_topic_score_gemma":0.000114874,"domain_scores_codex":[0.9982475,0.00006546656,0.00060011,0.0001636178,0.0006444515,0.0002788656],"domain_scores_gemma":[0.9985375,0.0004715663,0.0002637778,0.0001699704,0.0001573002,0.0003998859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005513603,0.001690456,0.6656454,0.0003509607,0.0006856344,0.06726037,0.01103636,0.002840102,0.004418354,0.0004383858,0.08600014,0.1541203],"study_design_scores_gemma":[0.378945,0.009225267,0.5664623,0.001196825,0.001738852,0.01390038,0.001470567,0.0002566371,0.001385918,0.0008536722,0.02424556,0.0003190381],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741744,0.001318727,0.00005517991,0.02260355,0.0003176896,0.0002353821,0.000002824253,0.00003185962,0.001260332],"genre_scores_gemma":[0.9956025,0.0007847731,0.0004935265,0.0003172754,0.002583413,0.000007002677,0.00002227115,0.00002638198,0.000162829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3734314,"threshold_uncertainty_score":0.424357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02210377450626567,"score_gpt":0.2872056935525979,"score_spread":0.2651019190463322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}